![](/img/cover-not-exists.png)
Phase II Study of Axitinib in Sorafenib-Refractory Metastatic Renal Cell Carcinoma
Rini, B. I., Wilding, G., Hudes, G., Stadler, W. M., Kim, S., Tarazi, J., Rosbrook, B., Trask, P. C., Wood, L., Dutcher, J. P.Volume:
27
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/jco.2008.21.7034
Date:
September, 2009
File:
PDF, 141 KB
english, 2009